ISOMERASE THERAPEUTICS LTD has a total of 27 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2013. It filed its patents most often in United Kingdom, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are CAMBREX IEP GMBH, NSC TECHNOLOGIES LLC and PURIFICATION ENG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 14 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 2 | |
#6 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks | |
#5 | Basic materials chemistry | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Fermentation | |
#3 | Climate change adaptation technologies | |
#4 | Medical preparations | |
#5 | Heterocyclic compounds | |
#6 | Preservation of human bodies | |
#7 | Therapeutic chemical compounds | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Gregory Matthew Alan | 13 |
#2 | Wilkinson Barrie | 8 |
#3 | Moss Steven James | 8 |
#4 | Kendrew Steven Gary | 8 |
#5 | Reumerman Richard | 5 |
#6 | Wlodek Aleksandra Maria | 5 |
#7 | Jani Divyang | 5 |
Publication | Filing date | Title |
---|---|---|
GB202101009D0 | Novel methods | |
GB202001443D0 | Novel methods | |
GB201901043D0 | Novel methods | |
GB201813198D0 | Novel compounds | |
GB201715203D0 | Novel methods | |
GB201715089D0 | Novel methods | |
GB201712386D0 | Novel Methods | |
US2020024595A1 | Novel Methods | |
GB201711549D0 | Novel compounds | |
GB201705148D0 | Novel methods | |
GB201703657D0 | Novel Methods | |
GB201613130D0 | Novel methods | |
GB201520989D0 | Novel methods | |
GB201515571D0 | Novel methods | |
GB201312318D0 | Novel methods and compounds |